Silva, C. S., Eira, J., Ribeiro, C. A., Oliveira, Â., et al. (2017). Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis. Neurobiology of Aging, 59, 10 - 14.

Eira, J., Silva, C. S., Sousa, M. M., & Liz, M. A. (2016). The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders. Progress in Neurobiology, 141, 61 - 82.

Miranda, C. O., Teixeira, C. A., Sousa, V. F., Santos, T. E., et al. (2014). Primary bone marrow mesenchymal stromal cells rescue the axonal phenotype of twitcher mice. Cell Transplantation, 23(2), 239 - 252.

Gouvea, I. E., Kondo, M. Y., Assis, D. M., Alves, F. M., et al. (2013). Studies on the peptidase activity of transthyretin (TTR). Biochimie, 95(2), 215 - 223.

Liz, M. A., Leite, S. C., Juliano, L., Saraiva, M. J., et al. (2012). Transthyretin is a metallopeptidase with an inducible active site. Biochemical Journal, 443(3), 769 - 778.

Miranda, C. O., Teixeira, C. A., Liz, M. A., Sousa, V. F., et al. (2011). Systemic delivery of bone marrow-derived mesenchymal stromal cells diminishes neuropathology in a mouse model of Krabbe's disease. Stem Cells, 29(11), 1738 - 1751.

Liz, M. A., Mar, F. M., Franquinho, F., & Sousa, M. M. (2010). Aboard transthyretin: From transport to cleavage. IUBMB Life, 62(6), 429 - 435.

Franquinho, F., Liz, M. A., Nunes, A. F., Neto, E., et al. (2010). Neuropeptide y and osteoblast differentiation - The balance between the neuro-osteogenic network and local control: Review Article. FEBS Journal, 277(18), 3664 - 3674.

Nunes, A. F., Liz, M. A., Franquinho, F., Teixeira, L., et al. (2010). Neuropeptide y expression and function during osteoblast differentiation - Insights from transthyretin knockout mice. FEBS Journal, 277(1), 263 - 275.

Liz, M. A., Fleming, C. E., Nunes, A. F., Almeida, M. R., et al. (2009). Substrate specificity of transthyretin: Identification of natural substrates in the nervous system. Biochemical Journal, 419(2), 467 - 474.

Liz, M. A., Gomes, C. M., Saraiva, M. J., & Sousa, M. M. (2007). ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. Journal of Lipid Research, 48(11), 2385 - 2395.

Liz, M. A., & Sousa, M. M. (2005). Deciphering cryptic proteases. Cellular and Molecular Life Sciences, 62(9), 989 - 1002.

Liz, M. A., Faro, C. J., Saraiva, M. J., & Sousa, M. M. (2004). Transthyretin, a new cryptic protease. Journal of Biological Chemistry, 279(20), 21431 - 21438.